Cencora (COR)

NYSE Health Care Health Care Distributors S&P 500
$333.56
-6.12 (-1.80%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 04)
$4.66 vs $4.56 est.
Surprise +2.2%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 04, 2026Sep/2026$4.56$4.66+2.2%

Our record of COR's reports since we began tracking; it grows each quarter.

Latest results, in brief

All COR 8-K briefs →
Nov 4, 6:37 AM ET

Cencora Reports Q4 and Fiscal 2026 Results, Increases Dividend, and Issues Fiscal 2027 Outlook

Positive earnings 2.027.01

Cencora reported fourth-quarter fiscal 2026 revenue of $88.4 billion, up 5.5 percent, and full-year revenue of $337.4 billion, up 5.0 percent. The company also announced a 10 percent increase in its quarterly dividend and projected fiscal 2027 adjusted diluted earnings per share to be between $19.40 and $19.75.

  • Fourth-quarter fiscal 2026 revenue increased 5.5 percent to $88.4 billion compared to the prior year period.
  • Full-year fiscal 2026 GAAP diluted EPS was $17.95, and adjusted diluted EPS was $17.97.
  • The quarterly dividend was increased by 10 percent to $0.66 per common share, payable on November 30, 2026.
  • Fiscal 2027 adjusted diluted EPS is expected to range from $19.40 to $19.75, reflecting growth of 8 percent to 10 percent.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Jun 2026$84.75B+5.1% $3.94+11.9% $763.52M0.9%
Mar 2026$78.36B+3.8% $8.40+128.3% $1.64B2.1%
Dec 2025$85.93B+5.5% $2.87+14.8% $559.65M0.7%
Sep 2025$83.73B+5.9% $-1.74-4450.0% -$339.70M-0.4%
Jun 2025$80.66B+8.7% $3.52+45.5% $687.40M0.9%
Mar 2025$75.45B+10.3% $3.68+76.1% $717.87M1.0%
Dec 2024$81.49B+12.8% $2.50-16.1% $488.60M0.6%
Sep 2024$79.05B+14.7% $0.04-97.7% $3.38M0.0%

From Cencora's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$321.33B+9.3% $7.96+5.7%0.5%
FY2024$293.96B+12.1% $7.53-11.7%0.5%
FY2023$262.17B+9.9% $8.53+6.1%0.7%
FY2022$238.59B+11.5% $8.04+8.8%0.7%
FY2021$213.99B+12.7% $7.39—0.7%

Frequently asked questions

When is Cencora's next earnings date?

Cencora has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Cencora earn last quarter?

For the quarter ended Jun 2026, Cencora reported diluted EPS of $3.94 (+11.9% year over year) on revenue of $84.75B (+5.1%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.